Group items tagged

The mission of the Children's Heart Foundation is to fund promising research that advances the diagnosis, prevention, and treatment of congenital heart defects. In support of this mission, CHF awards grants of up to $100,000 in support of life-changing congenital heart defect research in the areas of clinical cardiology, basic science, population science, and the advancement of surgical/interventional techniques. Funding areas of interest include but are not limited to genetics; biochemistry; pharmacology; devices and procedural research (cardiac catheterization and surgery); neurodevelopmental and functional outcomes; quality and policy regarding delivery of care, coverage, and access; maternal environment and modifiable disease impact on fetuses with CHD; fetal diagnosis and intervention; and long-term care of adults with CHDs.

All Applicants and Awardees Must be AHA Professional Members For programs with deadlines after June 1, 2018, all applicants -- including Predoctoral and Postdoctoral Fellowship applicants -- must be American Heart Association Professional Members (memberships start at $81). Do not wait until the application deadline to renew or join. There is a 3-5 day waiting period to process membership. Applicants may renew or join via the Grants@Heart application site or by phone at 301-223-2307 or 800-787-8984. Beginning with award start dates on July 1, 2018, awardees must maintain AHA Professional Membership for the entire term of funding. AHA awardees may use their funding to pay AHA membership dues. System Requirements Applications are submitted to AHA through the Grants@Heart online system. It is accessible from any location with Internet capabilities, 24 hours a day, 7 days a week (except during scheduled maintenance).

The purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative epidemiology research in heart, lung, blood, and/or sleep diseases, disorders, and/or phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) aims to establish a new epidemiology cohort of at least 2000 participants to stimulate research on a wide range of heart, lung, blood, and/or sleep research hypotheses.

The Children's Heart Foundation's 2020 Call for Research Proposals is now open! The Children's Heart Foundation funds life-saving, life-changing congenital heart defect (CHD) research in clinical cardiology, translational research, population science, and advancement, prevention, detection of surgical and interventional techniques including, but not limited to the following areas:  Genetics Biochemistry Pharmacology Devices and procedural research (cardiac catheterization and surgery) Neurodevelopmental and functional outcomes Quality and policy regarding delivery of care, coverage, and access Maternal environment and modifiable disease impact on fetuses with CHD Fetal diagnosis and intervention Long-term care of adults with CHDs Technological development and advancements

NOTICE:  Applications are submitted to the American Heart Association via Grants@Heart, a Web-based application system.  Grants@Heart is scheduled to open on May 15, 2013.  In the meantime, please review the program listings, instructions and information in preparation for your application. 

The National Heart, Lung, and Blood Institute invites applications for a Research Coordinating Center (RCC) to support projects from RFA-HL-20-003 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR), to test late-stage (T4) implementation strategies for optimally and sustainably delivering proven-effective, evidence-based, multi-level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities and promote and improve population health in high-burden communities. The DECIPHeR RCC will coordinate activities across all of the DECIPHeR projects, including coordinating and managing in-person and virtual network steering committee meetings and working groups; promoting collaboration and communication among investigators and the broader research community; coordinating network outreach activities; promoting skills development in implementation science; organizing, establishing, and managing a global implementation data safety and monitoring board (DSMB); and providing clinical study and site monitoring for DECIPHeR awards. For the purpose of this FOA, T4 implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions into routine clinical and public health practice and community-based settings and maximize the positive impact on population health.

As health advances allow people to live longer, healthy aging has become an urgent frontier for research. The burden of age-related cognitive impairment - whether from Alzheimer's disease, vascular dysfunction, or other causes - is growing exponentially. To accelerate collaborative brain-aging research, the Paul G. Allen Frontiers Group and the American Heart Association/American Stroke Association are committing $43 million with additional partners to co-fund a new research initiative with the goal of shedding new light on how to better prevent, detect, and treat age-related cognitive impairment, including Alzheimer's disease.

The National Heart, Lung, and Blood Institute invites applications for a Research Coordinating Center (RCC) to support projects from RFA-HL-20-003 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR), which will test late-stage (T4) implementation research strategies for optimally and sustainably delivering proven-effective, evidence-based multi-level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and that promote and improve population health in high-burden communities (see RFA-HL-20-003). The DECIPHeR RCC will coordinate activities across all of the DECIPHeR projects, including coordinating and managing in-person and virtual network steering committee meetings and working groups; promoting collaboration and communication among investigators and the broader research community; coordinating network outreach activities; promoting skills development in implementation science; and organizing, implementing, and managing a global implementation data safety and monitoring board (DSMB) and providing clinical study and site monitoring for DECIPHeR awards. For the purpose of this FOA, late-stage (T4) implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions into routine clinical and public health practice and community-based settings and maximize the positive impact on population health.

Supported by the American Heart Association Strategically Focused Research Networks, there is a two-year postdoctoral fellowship opportunity listed by institution for the funded research networks. Fellows with a strong interest in either prevention, hypertension, disparities, women's health, or heart failure-related to cardiovascular disease and/or stroke research, commitment to multi-disciplinary team science approach at the population, clinical and basic science levels and excellent communication skills. The center fellow will be highly involved in the projects being proposed by their institution, will be encouraged to collaborate with fellows across the network, and work closely with their Center Director and Training Director on their Center's individualized multidisciplinary training plan. Please refer to the SFRN Awardees webpage for a detailed list of each institution's projects within the networks

The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to establish new and innovative epidemiology cohort studies that will prospectively follow at least 2,000 participants and are designed to study a wide range of research hypotheses related to heart, lung, blood, and/or sleep phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) will support activities required to establish a new cohort, including identification and recruitment of cohort participants, detailed baseline data collection on all participants, biospecimen collection and storage, study infrastructure, and data quality control and analysis.

This Funding Opportunity Announcement (FOA) seeks grant applications for a Research Coordinating Center (RCC) to support associated "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe)" UG3/UH3 phased cooperative agreements that propose to optimally and sustainably address late-stage implementation research questions to address the delivery of proven-effective prevention and treatment interventions for heart, lung, blood, and sleep (HLBS) comorbid diseases and disorders in people living with HIV (PLHIV) in World Bank designated low- and middle-income countries (LMICs) and Small Island Developing States (SIDS). For the purposes of this FOA, late-stage implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions in routine clinical, public health, and community-based settings and maximize the positive impact on population health. The RCC will coordinate the collaborative efforts of the global alliance of funded UG3/UH3 phased cooperative agreements conducting late-stage implementation research within the following geographical regions: East Asia and the Pacific, Europe and Central Asia, Latin America and the Caribbean, Middle East and North Africa, South Asia, and Sub-Saharan Africa. The HLB SIMPLe RCC will coordinate activities including in-person and virtual Network Steering Committee meetings, subcommittee meetings, and working groups; promote collaboration and communication among investigators and the broader research community; coordinate network outreach activities; coordinate joint research and capacity building efforts conducted across the HLB SIMPLe alliance; and organize, implement, and manage a global implementation research data safety and monitoring board (DSMB). Also listed under UG3/UH3

The State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health - FOA - DP13-1305 outlines an approach to preventing and reducing the risk factors associated with childhood and adult obesity, diabetes, heart disease, and stroke; it also addresses management of these chronic diseases. The activities and strategies outlined in this FOA (see logic model on page 7) are organized by the four chronic disease prevention and health promotion domains: 1) Epidemiology and surveillance; 2) Environmental approaches that promote health and support and reinforce healthful behaviors; 3) Health system interventions to improve the effective delivery and use of clinical and other preventive services; and 4) Community-clinical linkages to support cardiovascular disease (CVD) and diabetes prevention and control efforts and the management of chronic diseases.

The American College of Cardiology's Accreditation Services help hospitals improve care for patients with acute coronary syndromes, heart failure, and atrial fibrillation. In 2016, ACC merged with the Society of Cardiovascular Patient Care (SCPC), a nonprofit organization dedicated to improving the care and outcomes of patients worldwide facing the same complications. To preserve the legacy of SCPC, an endowment was created to support future cardiovascular quality or performance improvement initiatives, particularly those that underscore the importance of accreditation. To advance that mission, ACCF is accepting proposals that support cardiovascular quality improvement of cardiovascular care and patient outcomes. Awards of up to $100,000 will support projects that contribute to the evidence base for accreditation; develop or evaluate cardiovascular quality initiatives that strengthen the accreditation process; provide opportunities for education that support quality or performance improvement projects; improve EMS systems of care in collaboration with community hospitals providing accreditation services; or provide public health education to improve community measures/outcomes related to early recognition of heart attack symptoms and appropriate action steps.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this National Heart, Lung, and Blood Institute (NHLBI) R25 program is to support mentoring and research education activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. The major goal of this R25 program is to establish long-term mentoring that will enable junior faculty who are underrepresented in the biomedical sciences as defined by NOT-OD-18-122, to develop a research program and obtain NIH funding. This FOA specifically invites applications from senior faculty, established researchers, and experienced mentors to develop and direct the Summer Institutes of the Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) program in order to mentor promising eligible junior faculty who have specific scientific interests in heart, lung, blood and sleep (HLBS) disorders research. To accomplish the stated overarching goal, this FOA will support creative educational activities with a primary focus on Research Experiences and Mentoring Activities.

This Funding Opportunity Announcement (FOA) is to support studies that are essential, yet also sufficient, for investigators to make definitive decisions about the designs of important clinical trials within NHLBI's mission, the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed pilot studies are both necessary and sufficient to permit definitive decisions about the design of the subsequent clinical trial. Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for this announcement. The NHLBI anticipates that the R34 award period will yield robust investigator-initiated clinical trial grant applications for the evaluation of interventions for the treatment or prevention of heart, lung, blood, or sleep disorders.

In an effort to support cardiovascular quality and performance improvement, the ACC provides funding opportunities that support future cardiovascular quality initiatives (QI) or performance improvement (PI), particularly those that highlight the importance of accreditation. Funding to support these projects is made possible by the Society of Cardiovascular Patient Care (SCPC), which was a nonprofit organization dedicated to improving the care and outcomes of patients worldwide with suspected acute coronary syndrome, heart failure, and atrial fibrillation through innovative cross-disciplinary processes. Its merger with the American College of Cardiology Foundation (ACCF) in 2016 provided an opportunity to leverage the accreditation strength of the SCPC into the large portfolio of services the ACCF offers. To preserve the legacy of the SCPC, an endowment was created to support future cardiovascular QI or PI, particularly those efforts that highlight the importance of accreditation. Focus areas of desired projects or proposals include those that support cardiovascular quality improvement of cardiovascular care and patient outcomes that: contribute to the evidence base for accreditation develop or evaluate cardiovascular quality initiatives that strengthen the accreditation process provide opportunities for education that support quality or performance improvement projects improve EMS systems of care in collaboration with community hospitals providing accreditation services provide public health education to improve community measures/outcomes related to early recognition of heart attack symptoms and appropriate action steps

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to build in-country capacity through the creation of a trans-disciplinary investigative team to guide the conduct of late-stage translation phase 4 research (T4TR) in low income countries (as defined by The World Bank) through skills development programming, needs assessment, and capacity building. Studies will be required to address chronic non-communicable heart, lung, blood and sleep diseases and disorders in low income countries.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to build in-country capacity through the creation of a trans-disciplinary investigative team to guide the conduct of late-stage translation phase 4 research (T4TR) in low income countries (as defined by The World Bank) through skills development programming, needs assessment, and capacity building. Studies will be required to address chronic non-communicable heart, lung, blood and sleep diseases and disorders in low income countries.

The purpose of this Funding Opportunity Announcement (FOA) is to support research to identify and evaluate the basic underlying molecular and physiological mechanisms by which the virome may influence heart, lung, and blood (HLB) health and resilience.

This FOA invites applications for a pragmatic clinical trial to establish efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia.

This Funding Opportunity Announcement (FOA) seeks late-stage T4 Translation research (T4TR) and implementation studies that will lead to generalizable new knowledge to accelerate the adoption/adaptation, and sustained, high-fidelity use of proven-effective interventions for the prevention, treatment, and control of heart, lung, blood, and sleep disorders or diseases (HLBS conditions). It calls for multi-level strategies for delivery of proven-effective interventions to promote the prevention and management of HLBS conditions. The system-level change(s) being evaluated are to be designed, and findings reported so that others would have a contextually-informed understanding of workflow, workforce, and trade-off considerations. These considerations should reflect cultural and organizational contextual factors and values as they inform feasibility and flexibility of adopting, adaptable and sustainable, proven-effective interventions to address HLBS conditions.